Relief Therapeutics' Wholly Owned Subsidiary, Apr Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Pku Golike. Technology clinical research enterprise software medical imaging medtech. ASSETS . Bioclinica, Inc. and JLL Partners, Inc. announce the successful completion of the tender offer for all of the outstanding shares of Bioclinica's commo . BioClinica offers Optimizer both through software licensing and as an outsourced service to make these benefits accessible to organizations of any size. It's authorized share capital is INR 5.00 lac and the total paid-up capital is INR 1.00 lac. Our expert teams work seamlessly across our divisions, where they continuously use their experience and knowledge to plan, develop and execute projects to exceptionally . View All with Free Trial. 26.04.2022. Menu; Plans & Pricing; About; Contact; . This General Services Agreement (this "Agreement") effective as of the last date of signature hereof (the "Effective Date"), by and between BioClinica, Inc., a Delaware Corporation, with its principal place of business at 826 Newtown-Yardley Road, Newtown, Pennsylvania, 18940-1721 ("BIOCLINICA") and Vascular . But the most successful trials require the ability to see key details and uncover hidden insights. Tags. Delivering Trial Anywhere with reliability and precision Item 1. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age. Bioclinica is a specialty clinical trial services provider that accelerates the development of new medical therapies.Clinical trials are a complex undertaking. 26.04.2022. 2009 . Financial Statements. Published: Jan 13, 2021 PRINCETON, N.J., Jan. 13, 2021 /PRNewswire/ -- Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced its partnership with IKCON PHARMA (subsidiary/affiliate of IKCON TECHNOLOGIES INC), a Clinical Research Organization (CRO) & technology services company. . Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details. Subsidiary. BIOCLINICA, INC. AND SUBSIDIARIES. Jan, 2021; Calls Received in the Last 12 Months (Drug Safety Solutions) 27 k: Clinical Trials Supported. Our expertise. Item 1. newtown, pa.-- ( business wire )--bioclinica, inc. (nasdaq: bioc), a leading global provider of clinical trial management solutions, and jll partners, inc., a leading private equity investment. Pfizer and BioNTech Submit Application for U.S. Further information can be found in the risk factors contained in the Annual Report of BioClinica, Inc. on Form 10-K for the year ended December 31, 2011 and most recent filings. 100,000. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age. BioClinica Holding I, LP operates as a holding company. 2 TO AGREEMENT AND PLAN OF MERGER (this "Amendment") is made and entered into as of May 19, 2009 by and among Bio-Imaging Technologies, Inc., a Delaware corporation ("Parent"), BioClinica Acquisition, Inc., a Delaware corporation and direct wholly-owned Subsidiary of Parent ("Merger Sub"), and etrials Worldwide . Bioclinica Inc 10-q - This Form 10 Q Quarterly Report Involves Bioclinica Inc. BioClinica is a subsidiary of Clario. The Central Index Key (CIK) for Bioclinica Inc is 822418. The Company, throughits subsidiaries, provides medical imaging, patient management, cardiac, payment, cloud hosting, and clinical. BioClinica Operating Metrics. PURPOSE 27.04.2022. It is classified as a private subsidiary of a foreign copmany and is located in Mysore, Karnataka. Type. References in this Quarterly Report on Form 10-Q to "BioClinica," "we," "us," or "our" refer to BioClinica, Inc., a Delaware corporation, and its subsidiaries, doing business as BioClinica. BioClinica Inc - Company Profile & SWOT Analysis, is a source of comprehensive company data and information. Its subsidiary Tevano Systems Inc. is the developer of Health Shield, an AI-driven, electronic tablet that video displays a user with their body temperature and other information. It provides . THIS AMENDMENT NO. Our platform integrates the broadest endpoint technologies, fused with deep scientific expertise and global scale. It is inolved in Software publishing, consultancy and supply [Software . The firm provides medical imaging support services including image processing and analysis, digitizing, archival services, and database maintenance. Type. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. -IKCON PHARMA INC a subsidiary/affiliate of IKCON TECHNOLOGIES INC is a clinical research, digital technology solutions and services provider supporting the life science industry has announced its partnership with Bioclinica, a world-leading provider of clinical science and technology expertise supporting the life science . Certain information and footnote disclosures required under generally accepted accounting principles (GAAP) in . Bioclinica is now Clario. Exhibit 10.10 . We provide a unique, combined approach to Clinical Development, Early Access Programs and Clinical Trial Supply. View All with Free Trial. 21 Subsidiaries. Menu; Plans & Pricing; About; . 4 k: Long-term Clients (Drug Safety Solutions) 35: Therapies Approved. The company's core products and services include medical imaging analysis and consultation, cardiovascular safety and efficacy, patient recruitment and retention, central lab services and e-health technologies thus enhancing the overall efficiency and productivity of clinical trials. These methods tend to focus on the system and . Subsidiary. Bioclinica Pharmaceutical Manufacturing Princeton, New Jersey 83,932 followers Bioclinica is now Clario. Clario is a technology company that generates the richest clinical evidence by fusing scientific expertise and global scale into the broadest endpoint . Bioclinica is a specialty clinical trial services provider that accelerates the development of new medical therapies. Bionical Emas stands with Ukraine. Current assets: . Organization Name: Bioclinica Inc: IRS EIN (Taxpayer Id) 11-2872047: CONSOLIDATED BALANCE SHEETS (unaudited) September 30, December 31, (in thousands) 2010 . Creating Clarity in Clinical Trials Clinical trials are complex and monolithic approaches are the norm. BioClinica is headquartered in Princeton, New Jersey, the US. PRINCETON, N.J., Jan. 13, 2021 /PRNewswire/ -- Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced its partnership with IKCON PHARMA (subsidiary/affiliate of IKCON TECHNOLOGIES INC), a Clinical Research Organization (CRO) & technology services company. Those who wish to participate in the conference call may telephone 877-869-3847 from the U.S.; international. BIOCLINICA, INC. AND SUBSIDIARIES. With 24/7 partner and patient support, along with training and instructions integrated into our devices, our technology and clinical trial . Bioclinica Inc - EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), made as of this 19th day of September, 2008, is entered into by Bio-Imaging Technologies, Inc., a Delaware corporation with its principal place of business at 826 Newtown-Yardley Road, Newtown, Pennsylvania 18940 (the "Company"), and Peter Benton (the "Employee"). BioClinica offers its services to pharmaceutical, biotechnology, medical device companies and contract research organizations. No financial terms were disclosed for the merger, which . Bioclinica India Private Limited is an unlisted private company incorporated on 08 December, 2008. Before You Go Don't miss your chance for 50 free email contacts and prospecting data right inside of your inbox. Subsidiary. Get a D&B Hoovers Free Trial. -IKCON PHARMA INC a subsidiary/affiliate of IKCON TECHNOLOGIES INC is a clinical research, digital technology solutions and services provider supporting the life science industry has announced its partnership with Bioclinica, a world-leading provider of clinical science and technology expertise supporting the life science . 9/30/12. The company has presence in North America, Latin America, Europe, and Asia. BIOCLINICA, INC. AND SUBSIDIARIES Consolidated Statements of Income (in thousands, except per share data) (unaudited) For the Three Months Ended. Jan 13, 2021, 09:30 ET PRINCETON, N.J., Jan. 13, 2021 /PRNewswire/ -- Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced its partnership. Corporation Parent. The report contains detailed information about BioClinica, Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history. newtown, pa.-- ( business wire )-- bioclinica, inc. ( nas: bioc) , a leading global provider of clinical trial management solutions, and jll partners, inc., a leading private equity investment. At Clario we are simplifying the clinical trial process for sponsors, sites, and CROs. References in this Quarterly Report on Form 10-Q to "BioClinica," "we," "us," or "our" refer to BioClinica, Inc., a Delaware corporation, and its subsidiaries, doing business as BioClinica. Highlights BioClinica Inc (BioClinica), formerly Bio-Imaging Technologies Inc, is a clinical trials services provider. . 2009 . BioClinica Agreement #40801 . BioClinica is headquartered in Princeton, New Jersey, the US. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company. 21st January 2014. by. 290 Mysuru, IN Public. Company Description: BioClinica helps drug developers keep track of their X-rays, MRIs, and other forms of medical imaging collected during clinical drug and medical device trials. Bioclinica Inc 10-K filing includes an Exhibit 21 subsidiary information. Financial Statements. SOUTH PLAINFIELD, NJ. 26.04.2022. Bioclinica India Private Limited is a Private incorporated on 08 December 2008. Type. It is one of the corporates which submit 10-K filings with the SEC. BioClinica Office Locations BioClinica has offices in Princeton, San Mateo, Shanghai, Mnchen and in 3 other locations Open Map View Princeton, NJ, US (HQ) 211 Carnegie Center Dr San Mateo, CA, US 777 Mariners Island Blvd # 550 Shanghai, CN 11F No.3, Lane 227, Dong Yu Road, Pudong New Area Mnchen, DE Landsberger Str. Pfizer and BioNTech Submit Application for U.S. Bioclinica Inc 10-K filing includes an Exhibit 21 subsidiary information. Basic Profile Business Address and Contact Details: It is classified as Subsidiary of Foreign Company and is registered at Registrar of Companies, Bangalore. | ERT, the global clinical endpoint technology leader, and Bioclinica, a technological and scientific leader in medical imaging, is now the combined company of Clario. Road, Newtown, Pennsylvania, 18940-1721 ("BIOCLINICA") and Vascular Biogenics Ltd. with its principal place of business at 6 Jonathan Netanyahu Street, Or Yehuda, Israel 60376 ("VASCULAR BIOGENICS"). 9/30/11. BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. 27.04.2022. SOUTH PLAINFIELD, NJ. Basic Profile. Relief Therapeutics' Wholly Owned Subsidiary, Apr Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Pku Golike. IVR/IWR Interactive Response Solutions The company has presence in North America, Latin America, Europe, and Asia. See jobs Follow View all 2,871 employees Overview Jobs Life About us ERT, the global. 26.04.2022. The . Contact Information Website www.bioclinica.com Formerly Known As Tags. Its authorized share capital is Rs. Type. While there are many companies available to support trials, many offer a monolithic approachone that is massive, indivisible, and rigid. BioClinica Inc Key Recent Developments BIOCLINICA and VASCULAR BIOGENICS are individually referred to as a "Party" and collectively as the "Parties". Company Name Date Deal Size; Compare BioClinica to its competitors by revenue, employee growth and other metrics at Craft. / Bioclinica, Inc. Bioclinica, Inc. Website. ASSETS As part of the partnership, IKCON PHARMA will have access to Bioclinica's . Bioclinica Inc 10-Q for BIOCLINICA INC - Sample agreements, legal documents, and contracts from RealDealDocs. 200: BioClinica Acquisitions / Subsidiaries. Our uniquely engineered and validated clinical trail management software, connected devices and artificial intelligence solutions across Cardiac Safety, eCOA, Medical Imaging, Precision Motion and Respiratory provide the broadest evidence generation platform in the industry. Key Highlights BioClinica Inc (BioClinica), formerly Bio-Imaging Technologies Inc, is a clinical trials services provider. Peter Mansell. BioClinica offers its services to pharmaceutical, biotechnology, medical device companies and contract research organizations. The Central Index Key (CIK) for Bioclinica Inc is 822418. BioClinica Optimizer is a product that allows biopharmaceutical companies to simulate and optimize their clinical supply chain. Certain information and footnote disclosures required under generally accepted accounting principles (GAAP) in . Scope OVERVIEW - BIOCLINICA INDIA PRIVATE LIMITED. 500,000 and its paid up capital is Rs. CONSOLIDATED BALANCE SHEETS (unaudited) September 30, December 31, (in thousands) 2010 . Management of BioClinica, Inc. will host a conference call today at 11:00 a.m. EST. GENERAL SERVICES AGREEMENT . For the Nine Months Ended. 23 Branches. Bioclinica Inc is incorporated in Delaware and the fiscal year end is in 31 December. a wholly-owned subsidiary of BioCore . Public. Bioclinica Inc is incorporated in Delaware and the fiscal year end is in 31 December. Our approach. Bioclinica | 84,026 followers on LinkedIn. BioClinica's main competitors include Calyx, Synexus, Veeva Systems and Cerner. CCBR-SYNARC and BioClinica, two US-based providers of specialised clinical-trial services, are merging their capabilities in medical imaging, patient recruitment, drug-development technology/consulting, cardiac safety and central-laboratory analysis.